Recently, the Shanghai Jiaotong University School of Medicine has completed a public announcement and authorized a Shanghai biotechnology company to implement an exclusive license for the Chinese invention patent “Antibody heavy chain constant region sequence for enhancing the activity of agonistic
Innovation is the first driving force for development, and protecting intellectual property rights is protecting innovation. In the field of home appliances, Haier is the company with the most overseas invention patents in China, with more than 11,000 patent applications overseas. While establishing
Due to patent infringement disputes, the enterprise dissatisfied with the administrative agency's decision and sued the Court. This administrative lawsuit was brought to the Supreme People's Court. At the end of last year, the Supreme People's Court concluded that the Wuhan Municipal Int
It was learned from the Guangzhou Intellectual Property Court on January 7th that in 2020, the Court newly received 6,905 pieces of patent cases of various types, and the total amount of newly received patent cases reached 1.85 billion yuan. According to Li Ch
Hainan Haiyao announced on January 6 that the company has recently signed a "Patent Assignment Contract" for DHODH inhibitor S-416 related patents with East China University of Science and Technology. The University owns DHODH inhibitor S-416 relevant patent, the company received the
